These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 28281967

  • 1. Inhibition of Proliferation, Migration, and Invasion by Knockdown of Pyruvate Kinase-M2 (PKM2) in Ovarian Cancer SKOV3 and OVCAR3 Cells.
    Miao Y, Lu M, Yan Q, Li S, Feng Y.
    Oncol Res; 2016 Oct 27; 24(6):463-475. PubMed ID: 28281967
    [Abstract] [Full Text] [Related]

  • 2. Knockdown of pyruvate kinase type M2 suppresses tumor survival and invasion in osteosarcoma cells both in vitro and in vivo.
    Yuan Q, Yu H, Chen J, Song X, Sun L.
    Exp Cell Res; 2018 Jan 01; 362(1):209-216. PubMed ID: 29155364
    [Abstract] [Full Text] [Related]

  • 3. M2 isoform of pyruvate kinase (PKM2) is upregulated in Kazakh's ESCC and promotes proliferation and migration of ESCC cells.
    Liu Q, Liang M, Liu T, Vuitton L, Zheng S, Gao X, Lu M, Li X, Sheyhidin I, Lu X.
    Tumour Biol; 2016 Feb 01; 37(2):2665-72. PubMed ID: 26404132
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of Pyruvate Kinase Type M2 (PKM2) Promotes Ovarian Cancer Cell Growth and Survival Via Regulation of Cell Cycle Progression Related with Upregulated CCND1 and Downregulated CDKN1A Expression.
    Zheng B, Liu F, Zeng L, Geng L, Ouyang X, Wang K, Huang Q.
    Med Sci Monit; 2018 May 12; 24():3103-3112. PubMed ID: 29752805
    [Abstract] [Full Text] [Related]

  • 5. Follicle-stimulating hormone promoted pyruvate kinase isozyme type M2-induced glycolysis and proliferation of ovarian cancer cells.
    Li S, Ji X, Wang R, Miao Y.
    Arch Gynecol Obstet; 2019 May 12; 299(5):1443-1451. PubMed ID: 30809696
    [Abstract] [Full Text] [Related]

  • 6. PKM2 gene regulates the behavior of pancreatic cancer cells via mitogen-activated protein kinase pathways.
    Feng J, Ma T, Ge Z, Lin J, Ding W, Chen H, Zhu W, Zhou S, Tan Y.
    Mol Med Rep; 2015 Mar 12; 11(3):2111-7. PubMed ID: 25411978
    [Abstract] [Full Text] [Related]

  • 7. Effect of siRNA-silencing of SALL2 gene on growth, migration and invasion of human ovarian carcinoma A2780 cells.
    Miao F, Zhang X, Cao Y, Wang Y, Zhang X.
    BMC Cancer; 2017 Dec 11; 17(1):838. PubMed ID: 29228922
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
    Chen YL, Song JJ, Chen XC, Xu W, Zhi Q, Liu YP, Xu HZ, Pan JS, Ren JL, Guleng B.
    World J Gastroenterol; 2015 Aug 14; 21(30):9093-102. PubMed ID: 26290635
    [Abstract] [Full Text] [Related]

  • 9. Pyruvate Kinase M2 Knockdown Suppresses Migration, Invasion, and Epithelial-Mesenchymal Transition of Gastric Carcinoma via Hypoxia-Inducible Factor Alpha/B-Cell Lymphoma 6 Pathway.
    Li N, Meng D, Xu Y, Gao L, Shen F, Tie X, Zhang Y, Yi Z, Shen W, Liu Z, Xu Z.
    Biomed Res Int; 2020 Aug 14; 2020():7467104. PubMed ID: 33376737
    [Abstract] [Full Text] [Related]

  • 10. Enhanced expression of the M2 isoform of pyruvate kinase is involved in gastric cancer development by regulating cancer-specific metabolism.
    Shiroki T, Yokoyama M, Tanuma N, Maejima R, Tamai K, Yamaguchi K, Oikawa T, Noguchi T, Miura K, Fujiya T, Shima H, Sato I, Murata-Kamiya N, Hatakeyama M, Iijima K, Shimosegawa T, Satoh K.
    Cancer Sci; 2017 May 14; 108(5):931-940. PubMed ID: 28235245
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of matrix metalloproteinase 9 by small interfering RNA inhibits the tumor growth of ovarian epithelial carcinoma in vitro and in vivo.
    Guo F, Tian J, Cui M, Fang M, Yang L.
    Mol Med Rep; 2015 Jul 14; 12(1):753-9. PubMed ID: 25738807
    [Abstract] [Full Text] [Related]

  • 12. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X, Chen S, Xiu YL, Sun KX, Zong ZH, Zhao Y.
    Mol Cancer; 2015 Feb 04; 14(1):31. PubMed ID: 25649143
    [Abstract] [Full Text] [Related]

  • 13. SUMOylation of HSP27 regulates PKM2 to promote esophageal squamous cell carcinoma progression.
    Zhang X, Liu T, Zheng S, Liu Q, Shen T, Han X, Zhang Q, Yang L, Lu X.
    Oncol Rep; 2020 Oct 04; 44(4):1355-1364. PubMed ID: 32945483
    [Abstract] [Full Text] [Related]

  • 14. Pyruvate kinase M2 plays a dual role on regulation of the EGF/EGFR signaling via E-cadherin-dependent manner in gastric cancer cells.
    Wang LY, Liu YP, Chen LG, Chen YL, Tan L, Liu JJ, Jazag A, Ren JL, Guleng B.
    PLoS One; 2013 Oct 04; 8(6):e67542. PubMed ID: 23840737
    [Abstract] [Full Text] [Related]

  • 15. Effects of shRNA-Mediated Silencing of PKM2 Gene on Aerobic Glycolysis, Cell Migration, Cell Invasion, and Apoptosis in Colorectal Cancer Cells.
    Yan XL, Zhang XB, Ao R, Guan L.
    J Cell Biochem; 2017 Dec 04; 118(12):4792-4803. PubMed ID: 28543190
    [Abstract] [Full Text] [Related]

  • 16. Pyruvate kinase M2 inhibits the progression of bladder cancer by targeting MAKP pathway.
    Zhu Q, Hong B, Zhang L, Wang J.
    J Cancer Res Ther; 2018 Sep 04; 14(Supplement):S616-S621. PubMed ID: 30249877
    [Abstract] [Full Text] [Related]

  • 17. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in cervical cancer.
    Guo M, Zhao X, Yuan X, Jiang J, Li P.
    Oncotarget; 2017 Apr 25; 8(17):28226-28236. PubMed ID: 28415668
    [Abstract] [Full Text] [Related]

  • 18. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
    Zhao Y, Zheng HC, Chen S, Gou WF, Xiao LJ, Niu ZF.
    Gynecol Oncol; 2013 Sep 25; 130(3):570-8. PubMed ID: 23764197
    [Abstract] [Full Text] [Related]

  • 19. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
    Zheng X, Zhou Y, Chen W, Chen L, Lu J, He F, Li X, Zhao L.
    Cell Physiol Biochem; 2018 Sep 25; 51(3):1340-1353. PubMed ID: 30481782
    [Abstract] [Full Text] [Related]

  • 20. Both high expression of pyruvate kinase M2 and vascular endothelial growth factor-C predicts poorer prognosis in human breast cancer.
    Lin Y, Liu F, Fan Y, Qian X, Lang R, Gu F, Gu J, Fu L.
    Int J Clin Exp Pathol; 2015 Sep 25; 8(7):8028-37. PubMed ID: 26339369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.